Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Titel:
Tofacitinib, an oral Janus kinase inhibitor, in patients from Mexico with rheumatoid arthritis: Pooled efficacy and safety analyses from Phase 3 and LTE studies
Auteur:
Burgos-Vargas, Ruben Cardiel, Mario Xibillèc), Daniel Pacheco-Tena, Cèc)sar Pascual-Ramos, Virginia Abud-Mendoza, Carlos Mahgoub, Ehab Rahman, Mahboob Fan, Haiyun Rojo, Ricardo García, Erika Santana, Karina
Verschenen in:
Reumatologia clinica (English edition)
Paginering:
Jaargang 15 (2019) nr. 1 pagina's 43-53
Jaar:
2019
Inhoud:
Uitgever:
Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología